A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia
- 1 July 1974
- journal article
- clinical trial
- Published by Elsevier
- Vol. 10 (7) , 413-418
- https://doi.org/10.1016/0014-2964(74)90023-1
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Management of Adult Acute Myelogenous LeukaemiaBMJ, 1973
- The Treatment of Acute Granulocytic Leukemia in AdultsNew England Journal of Medicine, 1972
- Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous LeukaemiaBMJ, 1970
- Treatment of adult acute leukemia with arabinosylcytosine and thioguanineCancer, 1969